Trademark: 79138125
Word
VALNEVA
Status Date
Monday, November 30, 2020
Registration Number
4686292
Registration Date
Tuesday, February 17, 2015
Filing Date
Friday, May 31, 2013
Published for Opposition
Tuesday, December 2, 2014
5 Pharmaceuticals for human and veterinary use for the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; antibodies and fragments thereof for use in disease testing; cell cultures, microorganisms and viruses for medical and veterinary use; diagnostic agents for medical, pharmaceutical and veterinary use; cells for medical or clinical use; culture media for cultivating microorganism cells for medical and veterinary use; adjuvants for medical or and veterinary use; pharmaceutical and veterinary preparations for medical, pharmaceutical and veterinary use, namely, preparations of encapsulated cells which release antibodies, living cells and microorganisms, vaccines, viral vectors, proteins, peptides, enzymes, nucleic acids or pharmaceutically active compounds for the treatment of cancer, auto-immune disorders, infectious diseases, inflammatory diseases, neurological and genetic disorders, bowel diseases, and digestion problems
1 Chemicals for use in industry, science and agriculture, except fungicides, herbicides, insecticides and parasiticides; molecules from biotechnologies, namely, proteins in raw material for industrial use, scientific or medical research; cells and cell lines for use in scientific, laboratory, or medical research; nucleic acids for laboratory use; proteins in raw material form for scientific and medical research; recombinant proteins in raw material form for scientific and medical research; Biomedical compounds, namely, peptide substrates and peptide antigens used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biochemical preparations derived from blood serum used as growth promoters in tissue cultures and microbiological media; Biochemicals, namely, antibodies and fragments thereof for in vitro scientific or research use; Chemicals for use in biotechnological product development; Cultures of microorganisms other than for medical and veterinary use; Biological preparations and bacteriological preparations for use in cell cultures other than for medical or veterinary use
42 Scientific research services for medical purposes in the fields of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research for medical, pharmaceutical and veterinary purposes in the fields of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research, in particular, in the fields of biology, cellular and molecular biology, biotechnology, bacteriology, immunology, genetics, medicine, pharmacology, virology, chemistry; scientific research relating to vaccines, antibiotics and immunological products for human and veterinary use; research and development of new products for others; testing, analysis, and evaluation of the goods of others to assure compliance with industry standards in the scientific, medical and veterinary fields; development and design of laboratory instruments for scientific and industrial research, in particular, to obtain and prepare cells, cell lines, viruses, proteins, animal and human materials; development of vaccines, antibiotics and immunological products for human and veterinary use; scientific and technological services, namely, diagnostic and prognostic analyses in the fields of cells, cell lines, animal and human materials, microorganisms, molecules for scientific purposes; scientific research, namely, preparation of scientific experts opinions reports
Color is not claimed as a feature of the mark.
Nov 19, 2013
Application Filing Receipt Mailed
Nov 11, 2013
Sn Assigned For Sect 66a Appl From Ib
Nov 13, 2013
New Application Office Supplied Data Entered
Nov 13, 2013
Assigned To Examiner
Nov 15, 2013
Non-Final Action Written
Nov 16, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Oct 9, 2014
Examiners Amendment -Written
Nov 20, 2013
Refusal Processed By Mpu
Nov 20, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Dec 10, 2013
Refusal Processed By Ib
Apr 9, 2014
Teas Response To Office Action Received
Apr 9, 2014
Correspondence Received In Law Office
Apr 9, 2014
Teas/Email Correspondence Entered
Apr 24, 2014
Final Refusal Written
Apr 24, 2014
Final Refusal E-Mailed
Apr 24, 2014
Notification Of Final Refusal Emailed
Oct 9, 2014
Examiners Amendment E-Mailed
Oct 9, 2014
Notification Of Examiners Amendment E-Mailed
Oct 9, 2014
Examiner's Amendment Entered
Oct 9, 2014
Approved For Pub - Principal Register
Feb 17, 2015
Registered-Principal Register
Oct 28, 2014
Assigned To Lie
Oct 29, 2014
Law Office Publication Review Completed
Nov 12, 2014
Notification Of Notice Of Publication E-Mailed
Dec 2, 2014
Published For Opposition
Dec 2, 2014
Official Gazette Publication Confirmation E-Mailed
May 17, 2015
Final Disposition Notice Created, To Be Sent To Ib
Jun 29, 2015
Final Disposition Processed
Jun 29, 2015
Final Disposition Notice Sent To Ib
Jul 31, 2015
Final Decision Transaction Processed By Ib
Dec 22, 2016
Change Of Name/Address Rec'd From Ib
Dec 13, 2018
Change Of Name/Address Rec'd From Ib
Sep 26, 2019
New Representative At Ib Received
Feb 17, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 8, 2020
Teas Section 71 & 15 Received
Nov 24, 2020
Case Assigned To Post Registration Paralegal
Nov 30, 2020
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Apr 7, 2023
International Registration Renewed
Nov 30, 2020
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Oct 1, 2022
Restriction Of Holder's Right Of Disposal Received
Oct 15, 2022
New Representative At Ib Received
Nov 3, 2022
Limitation From The Ib Examined, No Action Is Needed
Apr 25, 2024
Limitation From The Ib Examined, No Action Is Needed
Feb 17, 2024
Restriction Of Holder's Right Of Disposal Received
Feb 17, 2024
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Feb 25, 2024
Restriction Of Holder's Right Of Disposal Received
May 22, 2024
Limitation From The Ib Examined, No Action Is Needed
Trademark Alertz updated from USPTO on 2030-01-24
